INIS
patients
100%
cancer
100%
photons
100%
cost
100%
protons
100%
radiotherapy
100%
lung cells
100%
values
15%
tissues
15%
toxicity
15%
probability
15%
sensitivity
7%
information
7%
comparative evaluations
7%
radiations
7%
personnel
7%
Keyphrases
Cost-effectiveness
100%
Non-small Cell Lung Cancer Patients
100%
Model-based Approach
100%
Proton Radiotherapy
100%
Photon Radiotherapy
100%
Cost-effective Strategy
37%
Patient Selection
25%
Incremental Cost
25%
Normal Tissue Complication Probability Models
25%
Dysphagia
12%
Dutch
12%
Treatment Strategy
12%
Clinical Treatment
12%
Dyspnea
12%
Non-small Cell Lung Cancer (NSCLC)
12%
Stage III Non-small Cell Lung Cancer
12%
Cardiotoxicity
12%
Clinical Experience
12%
Decision-analytic Model
12%
Treatment Costs
12%
QALYs Gained
12%
Radiation Toxicity
12%
Value of Information Analysis
12%
Personnel Costs
12%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
Non Small Cell Lung Cancer
100%
Proton Therapy
100%
Photon Therapy
100%
Quality Adjusted Life Year
36%
Dyspnea
9%
Plummer-Vinson Syndrome
9%
Patient Selection
9%
Cardiotoxicity
9%
Treatment of Non-Small Cell Lung Cancer
9%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Non Small Cell Lung Cancer
100%
Proton Therapy
100%
Photon Therapy
100%
Quality Adjusted Life Year
50%
Dyspnea
12%
Dysphagia
12%
Patient Selection
12%
Cardiotoxicity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Dyspnea
33%
Cardiotoxicity
33%
Dysphagia
33%
Biochemistry, Genetics and Molecular Biology
Quality Adjusted Life Year
100%